These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22067662)

  • 1. Return on public health investment: CDC's Expanded HIV Testing Initiative.
    Hutchinson AB; Farnham PG; Duffy N; Wolitski RJ; Sansom SL; Dooley SW; Cleveland JC; Mermin JH
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):281-6. PubMed ID: 22067662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return on Investment From Expenditures Incurred to Eliminate Mother-To-Child Transmission Among HIV-Infected Women in New York State: 1998-2013.
    Laufer FN; Warren BL; Pulver WP; Smith LC; Wright RL; Birkhead GS
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):558-62. PubMed ID: 26974414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC.
    Castel AD; Choi S; Dor A; Skillicorn J; Peterson J; Rocha N; Kharfen M
    PLoS One; 2015; 10(10):e0139605. PubMed ID: 26465771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmes for the prevention of mother-to-child HIV infection transmission have made progress in Yunnan Province, China, from 2006 to 2015: a cost effective and cost-benefit evaluation.
    Wang X; Guo G; Zheng J; Lu L
    BMC Infect Dis; 2019 Jan; 19(1):64. PubMed ID: 30654744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in HIV Testing Among US Adults, Aged 18-64 Years, 2011-2017.
    Patel D; Johnson CH; Krueger A; Maciak B; Belcher L; Harris N; DiNenno EA
    AIDS Behav; 2020 Feb; 24(2):532-539. PubMed ID: 31595375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
    Farnham PG; Sansom SL; Hutchinson AB
    Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States.
    Zulliger R; Maulsby C; Solomon L; Baytop C; Orr A; Nasrullah M; Shouse L; DiNenno E; Holtgrave D
    AIDS Behav; 2017 Mar; 21(3):619-625. PubMed ID: 27624729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons Learned From Measuring Return on Investment in Public Health Quality Improvement Initiatives.
    Crawley-Stout LA; Ward KA; See CH; Randolph G
    J Public Health Manag Pract; 2016; 22(2):E28-37. PubMed ID: 25723876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.
    Hutchinson AB; Farnham PG; Sansom SL; Yaylali E; Mermin JH
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):323-30. PubMed ID: 26361172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.
    Schrappe M; Lauterbach K
    AIDS; 1998; 12 Suppl A():S231-8. PubMed ID: 9633007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs.
    Jain KM; Maulsby C; Brantley M; ; Kim JJ; Zulliger R; Riordan M; Charles V; Holtgrave DR
    AIDS Care; 2016 Sep; 28(9):1199-204. PubMed ID: 27017972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States.
    Holtgrave DR; Pinkerton SD
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):171-4. PubMed ID: 12794550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
    Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
    JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.